Psoriatic Arthritis Clinical Trial
Official title:
Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic Arthritis
Verified date | September 2020 |
Source | Izmir Katip Celebi University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to assess hand functions and wrist joint position sense in patients with and without PsA.
Status | Completed |
Enrollment | 54 |
Est. completion date | August 30, 2020 |
Est. primary completion date | June 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - to be diagnosed according to CASPAR or ACR/ EULAR 2010 criteria for patient groups - taking regular medication for patient groups, - have complaints related to hand / wrist joints for patients groups, - have no complaints related to upper extremity for asymptomatic healthy group. - have any rheumatologic disease and OA diagnosed according to traditional criteria Exclusion Criteria: - finger infection and / or finger amputation, - using orthoses, - to report a diagnosis of neurological disease, - to report a history of trauma or surgery involving the upper extremity, - to report a psychiatric and / or cognitive problem |
Country | Name | City | State |
---|---|---|---|
Turkey | Izmir Katip Celebi University Ataturk Research and Training Hospital | Izmir | Izmir/ Cigli |
Lead Sponsor | Collaborator |
---|---|
Melissa Köprülüoglu |
Turkey,
Feced Olmos CM, Alvarez-Calderon O, Hervás Marín D, Ivorra Cortés J, Pujol Marco C, Román Ivorra JA. Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients. Clin Biomech (Bristol, Avon). 2019 Aug;68:169-174. doi: 10.1016/j.clinbiomech.2019.06.009. Epub 2019 Jun 11. Erratum in: Clin Biomech (Bristol, Avon). 2020 Feb;72:212. — View Citation
Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 Jun;29(6):602-8. Erratum in: Am J Ind Med 1996 Sep;30(3):372. — View Citation
INNES, E. V. Handgrip strength testing: a review of the literature. Australian Occupational Therapy Journal, 1999, 46.3: 120-140.
Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984 Mar;9(2):222-6. — View Citation
Navsarikar A, Gladman DD, Husted JA, Cook RJ. Validity assessment of the disabilities of arm, shoulder, and hand questionnaire (DASH) for patients with psoriatic arthritis. J Rheumatol. 1999 Oct;26(10):2191-4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Grip Strength | Grip strenght was examined using a hand dynamometer (Lafayette Proffessional Hand Held Dynamometer, USA). | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. | |
Secondary | Two-Point Pinch Strength | It was evaluated by pinchmeter (Lafayette,USA). | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. | |
Secondary | Three-Point Pinch Strength | It was evaluated by pinchmeter (Lafayette,USA). | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. | |
Secondary | Lateral Pinch Strength | It was evaluated by pinchmeter (Lafayette,USA). | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. | |
Secondary | DASH score | The DASH score provides information about the general functionality of the upper extremity and especially activities of hand. | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. | |
Secondary | Wrist Joint Position Sense | Wrist joint position sense was evaluated by goniometric re-position error test ( in 30? wrist extansion, 3 repeat ). | Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04152759 -
Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT01925768 -
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
|
Phase 3 | |
Completed |
NCT01892436 -
Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
|
Phase 3 | |
Completed |
NCT01212770 -
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
|
Phase 3 | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Completed |
NCT01212757 -
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
|
Phase 3 | |
Completed |
NCT03953378 -
CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis
|
||
Recruiting |
NCT02572700 -
Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
|
||
Completed |
NCT02556034 -
Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.
|
||
Completed |
NCT02154425 -
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
|
Phase 1 | |
Completed |
NCT02188654 -
Metformin in Psoriatic Arthritis
|
N/A | |
Completed |
NCT02164214 -
Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?
|
Phase 3 | |
Completed |
NCT01392326 -
Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)
|
Phase 3 | |
Completed |
NCT01083693 -
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
|
N/A | |
Not yet recruiting |
NCT00517101 -
Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
|
N/A | |
Completed |
NCT00133315 -
TNFalfa Blocking Treatment of Spondylarthropathies
|
Phase 4 | |
Completed |
NCT00659412 -
A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis
|
Phase 2 | |
Completed |
NCT00946686 -
To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
|
Phase 1 | |
Not yet recruiting |
NCT06059430 -
Cohort Project of Patients With Inflammatory Rheumatism
|